EUVIMEDEUVIMED entdecken
Open Access

Remdesivir Resistance in Transplant Recipients With Persistent Coronavirus Disease 2019

John I Hogan, Ralf Duerr, Dacia Dimartino, Christian Marier, Sarah E Hochman, Sapna Mehta, Guiqing Wang, Adriana Heguy iD

Clinical Infectious Diseases · 13.01.2023 · 76 (2) · 342-345

DOI: 10.1093/cid/ciac769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 26.09.2022. Verfasst von John I Hogan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, NYU Long Island School of Medicine, Mineola, New York, USA. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NYU Langone Health, Genome Technology Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New mutations conferring resistance to SARS-CoV-2 therapeutics have important clinical implications. We describe the first cases of an independently acquired V792I RNA-dependent RNA polymerase mutation developing in renal transplant recipients after remdesivir exposure. Our work underscores the need for augmented efforts to identify concerning mutations and address their clinical implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansSARS-CoV-2Antiviral AgentsTransplant RecipientsCOVID-19 Drug TreatmentAdenosine MonophosphateAlanine

Stichwörter der Autor:innen

antiviral resistanceimmunocompromiseremdesivirsevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)solid-organ transplant

Substanzen

Antiviral AgentsremdesivirAdenosine MonophosphateAlanine

Autor:innen und Institutionen

  • Department of Medicine, NYU Long Island School of Medicine, Mineola, New York, USA.
  • Department of Microbiology, NYU Grossman School of Medicine, New York, New York, USA.
  • Genome Technology Center, NYU Langone Health, New York, New York, USA.
  • Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA.

ORCID-Profile: Adriana Heguy

Förderung

  • NCI NIH HHS
  • NYU Langone Health
  • Genome Technology Center

Zitieren

APA

Hogan, J. I., Duerr, R., Dimartino, D., Marier, C., Hochman, S. E., Mehta, S., Wang, G., & Heguy, A. (2023). Remdesivir Resistance in Transplant Recipients With Persistent Coronavirus Disease 2019. Clinical Infectious Diseases, 76(2), 342-345. https://doi.org/10.1093/cid/ciac769

Vancouver

Hogan JI, Duerr R, Dimartino D, Marier C, Hochman SE, Mehta S, et al. Remdesivir Resistance in Transplant Recipients With Persistent Coronavirus Disease 2019. Clinical Infectious Diseases. 2023;76(2):342-345. doi:10.1093/cid/ciac769

BibTeX
@article{Hogan2023,
  author = {Hogan, John I and Duerr, Ralf and Dimartino, Dacia and Marier, Christian and Hochman, Sarah E and Mehta, Sapna and Wang, Guiqing and Heguy, Adriana},
  title = {Remdesivir Resistance in Transplant Recipients With Persistent Coronavirus Disease 2019},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {76},
  number = {2},
  pages = {342--345},
  doi = {10.1093/cid/ciac769}
}
Kostenlos starten →